Tuesday, September 18, 2018

Equillium Files For IPO

La Jolla-based Equillium, a developer of treatments for autoimmune and inflammatory diseases, has filed for an IPO on The Nasdaq Global Market. Equillium said it is looking to raise up to $86.25M in its offering, and says it has applied to list as EQ. The IPO is being underwritten by Jefferies, Leerink Partners, and Stifel. Equilium's main backer is

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.